Sterling

Valneva vs GSK vs Pfizer and 1 More Revenue Comparison

Compare financial metrics side-by-side using real SEC EDGAR data

Valneva logo
Valneva
GSK logo
GSK
Pfizer logo
Pfizer
Merck & Co. logo
Merck & Co.

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Valneva 0.038, GSK 11.109, Pfizer 16.583, Merck & Co. 18.085.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Valneva, GSK, Pfizer, Merck & Co..
MetricValnevaGSKPfizerMerck & Co.
Market Cap$516.54M$97.68B$160.31B$344.11B
Revenue$38.00M$11.11B$16.58B$18.09B
Cost of Revenue$37.00M$2.84B$4.03B$4.89B
Gross Profit$2.00M$8.27B$12.55B$13.19B
Operating Income$-30.00M$3.21B$3.67B$5.59B
Net Income$-34.00M$1.93B$3.24B$5.07B
R&D Expense$16.00M$2.34B$3.02B$4.54B
Earnings Per Share-$0.37$0.96$0.56$2.04
Gross Margin4.6%74.5%75.7%73.0%
Operating Margin-77.8%28.9%22.1%30.9%
Net Profit Margin-89.3%17.4%19.6%28.0%
Free Cash Flow$-20.00M$3.04B$4.80B$5.52B
Cumulative Free Cash Flow$-689.00M$160.25B$361.51B$255.22B
Operating Cash Flow$-20.00M$3.51B$5.38B$6.56B
Cash & Equivalents$131.00M$3.72B$1.82B$9.55B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites